SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-044670
Filing Date
2005-03-08
Accepted
2005-03-08 16:47:15
Documents
7
Period of Report
2005-01-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2005 d10q.htm 10-Q 297266
2 FORM OF STOCK OPTION AGREEMENT FOR EXECUTIVE OFFICERS (FORM A). dex101.htm EX-10.1 21217
3 FORM OF STOCK OPTION AGREEMENT FOR EXECUTIVE OFFICERS (FORM B). dex102.htm EX-10.2 43748
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8129
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8133
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4042
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4066
  Complete submission text file 0001193125-05-044670.txt   388960
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-27756 | Film No.: 05667222
SIC: 2834 Pharmaceutical Preparations